Cancer Care Ontario | Cancer Care Ontario

11 Results

Drug

olaparib

Other Name(s): Lynparza®

Quick Link(s): Drug Monograph, Patient Info Sheet

Jan 2025

Drug

teclistamab

Other Name(s): Tecvayli®

Quick Link(s): Drug Monograph, Patient Info Sheet

Jan 2025

Guidelines and Advice

The Use of Molecular Tools for Identifying and Guiding Treatment of Cancers of Unknown Primary

Status: Current
ID: MOTAC-7

Updated

Jan 2025

Drug

treosulfan

Other Name(s): Trecondyv®

Quick Link(s): Drug Monograph

Jan 2025

Drug

tucatinib

Other Name(s): Tukysa™

Quick Link(s): Drug Monograph, Patient Info Sheet

Feb 2025

Regimen

TARL; TARL(RAMP)

Cancer Type:

Lung,

Small Cell

Show More Show more tags

, Show Less Show fewer tags

Intent: Palliative

Drugs Used:

tarlatamab (Compassionate)

... Show more tags

, Collapse Show fewer tags

Quick Link(s):

Regimen Monograph

Feb 2025

Guidelines and Advice

Ontario Cervical Screening Program: Interim guidance to support the transition years following the launch of human papillomavirus testing in Ontario: Cervical screening and colposcopy recommendations for people ages 21 to 24

Status: Current

Updated

Mar 2025

Guidelines and Advice

Ontario Cervical Screening Program recommendations for cervical screening and colposcopy with human papillomavirus testing in Ontario

Updated

Mar 2025

Guidelines and Advice

Ontario Cervical Screening Program: Guidance for Vaginal Vault Testing

Status: Current

Updated

Mar 2025

Guidelines and Advice

T-Cell Engaging Antibodies: Management of Cytokine Release Syndrome (CRS) and Immune Effector-Associated Neurotoxicity Syndrome (ICANS)

Status: Current

Updated

Mar 2025

Statistical Reports

Ontario Cancer Statistics 2024

Ontario Cancer Statistics 2024 is the fifth in a series of reports that provide comprehensive information on the burden of cancer in Ontario....

New

Feb 2025